United States Breast Cancer Screening Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Breast Cancer Screening Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Breast Cancer Screening Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Breast Cancer Screening Overall Market Size
2.1 United States Breast Cancer Screening Market Size: 2021 VS 2027
2.2 United States Breast Cancer Screening Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Breast Cancer Screening Sales: 2016-2027

3 Company Landscape
3.1 Top Breast Cancer Screening Players in United States Market
3.2 Top United States Breast Cancer Screening Companies Ranked by Revenue
3.3 United States Breast Cancer Screening Revenue by Companies
3.4 United States Breast Cancer Screening Sales by Companies
3.5 United States Breast Cancer Screening Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Breast Cancer Screening Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Breast Cancer Screening Product Type
3.8 Tier 1, Tier 2 and Tier 3 Breast Cancer Screening Players in United States Market
3.8.1 List of Tier 1 Breast Cancer Screening Companies in United States
3.8.2 List of Tier 2 and Tier 3 Breast Cancer Screening Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Breast Cancer Screening Market Size Markets, 2021 & 2027
4.1.2 Mammography Screening
4.1.3 Breast Magnetic Resonance Imaging (MRI) Screening
4.1.4 Breast Ultrasound Screening
4.2 By Type - United States Breast Cancer Screening Revenue & Forecasts
4.2.1 By Type - United States Breast Cancer Screening Revenue, 2016-2021
4.2.2 By Type - United States Breast Cancer Screening Revenue, 2022-2027
4.2.3 By Type - United States Breast Cancer Screening Revenue Market Share, 2016-2027
4.3 By Type - United States Breast Cancer Screening Sales & Forecasts
4.3.1 By Type - United States Breast Cancer Screening Sales, 2016-2021
4.3.2 By Type - United States Breast Cancer Screening Sales, 2022-2027
4.3.3 By Type - United States Breast Cancer Screening Sales Market Share, 2016-2027
4.4 By Type - United States Breast Cancer Screening Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Breast Cancer Screening Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - United States Breast Cancer Screening Revenue & Forecasts
5.2.1 By Application - United States Breast Cancer Screening Revenue, 2016-2021
5.2.2 By Application - United States Breast Cancer Screening Revenue, 2022-2027
5.2.3 By Application - United States Breast Cancer Screening Revenue Market Share, 2016-2027
5.3 By Application - United States Breast Cancer Screening Sales & Forecasts
5.3.1 By Application - United States Breast Cancer Screening Sales, 2016-2021
5.3.2 By Application - United States Breast Cancer Screening Sales, 2022-2027
5.3.3 By Application - United States Breast Cancer Screening Sales Market Share, 2016-2027
5.4 By Application - United States Breast Cancer Screening Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Hologic
6.1.1 Hologic Corporation Information
6.1.2 Hologic Overview
6.1.3 Hologic Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.1.4 Hologic Breast Cancer Screening Product Description
6.1.5 Hologic Recent Developments
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Overview
6.2.3 GE Healthcare Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.2.4 GE Healthcare Breast Cancer Screening Product Description
6.2.5 GE Healthcare Recent Developments
6.3 Siemen Healthineers
6.3.1 Siemen Healthineers Corporation Information
6.3.2 Siemen Healthineers Overview
6.3.3 Siemen Healthineers Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.3.4 Siemen Healthineers Breast Cancer Screening Product Description
6.3.5 Siemen Healthineers Recent Developments
6.4 Philips Healthcare
6.4.1 Philips Healthcare Corporation Information
6.4.2 Philips Healthcare Overview
6.4.3 Philips Healthcare Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.4.4 Philips Healthcare Breast Cancer Screening Product Description
6.4.5 Philips Healthcare Recent Developments
6.5 Canon Medical
6.5.1 Canon Medical Corporation Information
6.5.2 Canon Medical Overview
6.5.3 Canon Medical Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.5.4 Canon Medical Breast Cancer Screening Product Description
6.5.5 Canon Medical Recent Developments
6.6 Fujifilm
6.6.1 Fujifilm Corporation Information
6.6.2 Fujifilm Overview
6.6.3 Fujifilm Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.6.4 Fujifilm Breast Cancer Screening Product Description
6.6.5 Fujifilm Recent Developments
6.7 Metaltronica
6.7.1 Metaltronica Corporation Information
6.7.2 Metaltronica Overview
6.7.3 Metaltronica Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.7.4 Metaltronica Breast Cancer Screening Product Description
6.7.5 Metaltronica Recent Developments
6.8 Sino Medical-Device
6.8.1 Sino Medical-Device Corporation Information
6.8.2 Sino Medical-Device Overview
6.8.3 Sino Medical-Device Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.8.4 Sino Medical-Device Breast Cancer Screening Product Description
6.8.5 Sino Medical-Device Recent Developments
6.9 IMS Srl
6.9.1 IMS Srl Corporation Information
6.9.2 IMS Srl Overview
6.9.3 IMS Srl Breast Cancer Screening Sales and Revenue in United States Market (2016-2021)
6.9.4 IMS Srl Breast Cancer Screening Product Description
6.9.5 IMS Srl Recent Developments

7 United States Breast Cancer Screening Production Capacity, Analysis
7.1 United States Breast Cancer Screening Production Capacity, 2016-2027
7.2 Breast Cancer Screening Production Capacity of Key Manufacturers in United States Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Breast Cancer Screening Supply Chain Analysis
9.1 Breast Cancer Screening Industry Value Chain
9.2 Breast Cancer Screening Upstream Market
9.3 Breast Cancer Screening Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Breast Cancer Screening Distributors and Sales Agents in United States Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer

List of Tables
Table 1. Key Players of Breast Cancer Screening in United States Market
Table 2. Top Breast Cancer Screening Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Breast Cancer Screening Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Breast Cancer Screening Revenue Share by Companies, 2016-2021
Table 5. United States Breast Cancer Screening Sales by Companies, (Units), 2016-2021
Table 6. United States Breast Cancer Screening Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Breast Cancer Screening Price (2016-2021) & (K USD/Unit)
Table 8. Manufacturers Breast Cancer Screening Product Type
Table 9. List of Tier 1 Breast Cancer Screening Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Breast Cancer Screening Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Mammography Screening
Table 12. Major Manufacturers of Breast Magnetic Resonance Imaging (MRI) Screening
Table 13. By Type – United States Breast Cancer Screening Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Breast Cancer Screening Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Breast Cancer Screening Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Breast Cancer Screening Sales (Units), 2016-2021
Table 17. By Type - United States Breast Cancer Screening Sales (Units), 2022-2027
Table 18. By Application – United States Breast Cancer Screening Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Breast Cancer Screening Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Breast Cancer Screening Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Breast Cancer Screening Sales (Units), 2016-2021
Table 22. By Application - United States Breast Cancer Screening Sales (Units), 2022-2027
Table 23. Hologic Corporation Information
Table 24. Hologic Description and Major Businesses
Table 25. Hologic Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 26. Hologic Breast Cancer Screening Product
Table 27. Hologic Recent Developments
Table 28. GE Healthcare Corporation Information
Table 29. GE Healthcare Description and Major Businesses
Table 30. GE Healthcare Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 31. GE Healthcare Breast Cancer Screening Product
Table 32. GE Healthcare Recent Developments
Table 33. Siemen Healthineers Corporation Information
Table 34. Siemen Healthineers Description and Major Businesses
Table 35. Siemen Healthineers Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 36. Siemen Healthineers Breast Cancer Screening Product
Table 37. Siemen Healthineers Recent Developments
Table 38. Philips Healthcare Corporation Information
Table 39. Philips Healthcare Description and Major Businesses
Table 40. Philips Healthcare Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 41. Philips Healthcare Breast Cancer Screening Product
Table 42. Philips Healthcare Recent Developments
Table 43. Canon Medical Corporation Information
Table 44. Canon Medical Description and Major Businesses
Table 45. Canon Medical Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 46. Canon Medical Breast Cancer Screening Product
Table 47. Canon Medical Recent Developments
Table 48. Fujifilm Corporation Information
Table 49. Fujifilm Description and Major Businesses
Table 50. Fujifilm Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 51. Fujifilm Breast Cancer Screening Product
Table 52. Fujifilm Recent Developments
Table 53. Metaltronica Corporation Information
Table 54. Metaltronica Description and Major Businesses
Table 55. Metaltronica Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 56. Metaltronica Breast Cancer Screening Product
Table 57. Metaltronica Recent Developments
Table 58. Sino Medical-Device Corporation Information
Table 59. Sino Medical-Device Description and Major Businesses
Table 60. Sino Medical-Device Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 61. Sino Medical-Device Breast Cancer Screening Product
Table 62. Sino Medical-Device Recent Developments
Table 63. IMS Srl Corporation Information
Table 64. IMS Srl Description and Major Businesses
Table 65. IMS Srl Breast Cancer Screening Sales (Units), Revenue (US$, Mn) and Gross Margin (K USD/Unit) (2016-2021)
Table 66. IMS Srl Breast Cancer Screening Product
Table 67. IMS Srl Recent Developments
Table 68. Breast Cancer Screening Production Capacity (Units) of Key Manufacturers in United States Market, 2019-2021 (Units)
Table 69. United States Breast Cancer Screening Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Breast Cancer Screening Market Opportunities & Trends in United States Market
Table 71. Breast Cancer Screening Market Drivers in United States Market
Table 72. Breast Cancer Screening Market Restraints in United States Market
Table 73. Breast Cancer Screening Raw Materials
Table 74. Breast Cancer Screening Raw Materials Suppliers in United States Market
Table 75. Typical Breast Cancer Screening Downstream
Table 76. Breast Cancer Screening Downstream Clients in United States Market
Table 77. Breast Cancer Screening Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Breast Cancer Screening Product Picture
Figure 2. Breast Cancer Screening Segment by Type
Figure 3. Breast Cancer Screening Segment by Application
Figure 4. United States Breast Cancer Screening Market Overview: 2020
Figure 5. United States Breast Cancer Screening Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Breast Cancer Screening Revenue, 2016-2027 (US$, Mn)
Figure 7. Breast Cancer Screening Sales in United States Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Breast Cancer Screening Revenue in 2020
Figure 9. Mammography Screening Product Picture
Figure 10. Breast Magnetic Resonance Imaging (MRI) Screening Product Picture
Figure 11. Breast Ultrasound Screening Product Picture
Figure 12. By Type - United States Breast Cancer Screening Sales Market Share, 2016-2027
Figure 13. By Type - United States Breast Cancer Screening Revenue Market Share, 2016-2027
Figure 14. By Type - United States Breast Cancer Screening Price (K USD/Unit), 2016-2027
Figure 15. Hospital
Figure 16. Clinic
Figure 17. By Application - United States Breast Cancer Screening Sales Market Share, 2016-2027
Figure 18. By Application - United States Breast Cancer Screening Revenue Market Share, 2016-2027
Figure 19. By Application - United States Breast Cancer Screening Price (K USD/Unit), 2016-2027
Figure 20. Hologic Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. GE Healthcare Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Siemen Healthineers Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Philips Healthcare Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Canon Medical Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Fujifilm Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Metaltronica Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Sino Medical-Device Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. IMS Srl Breast Cancer Screening Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. United States Breast Cancer Screening Production Capacity (Units), 2016-2027
Figure 30. Breast Cancer Screening Industry Value Chain
Figure 31. Marketing Channels

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.